The total return over the past 12 months is -44.20% vs. +16.94% for the S&P 500. So far it's up -27.56% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (44.20%) | +3.08% | +15.72% | (12.08%) | N/A | N/A |
| Total Return CAGR | (44.20%) | +3.08% | +15.72% | (12.08%) | N/A | N/A |
| Revenue CAGR | (119.63%) | N/A | N/A | N/A | +27.36% | N/A |
| Net Income CAGR | (207.73%) | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | (207.66%) | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | (133.55%) | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | (121.87%) | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
BioStem Technologies, Inc. (BSEM)
| Year | Start price | End price | BSEM Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.81 | $2.76 | (27.56%) | +14.51% | (42.07%) |
| 2025 | $13.84 | $3.81 | (72.47%) | +17.72% | (90.19%) |
| 2024 | $5.86 | $13.84 | +136.18% | +24.89% | +111.29% |
| 2023 | $2.99 | $5.86 | +95.99% | +26.19% | +69.80% |
| 2022 | $1.04 | $2.99 | +187.50% | (18.17%) | +205.67% |
| 2021 | $1.45 | $1.04 | (28.28%) | +28.74% | (57.02%) |
| 2020 | $2.50 | $1.45 | (42.00%) | +18.37% | (60.37%) |
| 2019 | $3.20 | $2.50 | (21.88%) | +31.22% | (53.10%) |
| 2018 | $12.00 | $3.20 | (73.33%) | (4.56%) | (68.77%) |
| 2017 | $10.05 | $12.00 | +19.40% | +21.70% | (2.30%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
